AU2003294100A8 - Use of hyaluronic acid for respiratory disorders or the upper airways - Google Patents

Use of hyaluronic acid for respiratory disorders or the upper airways

Info

Publication number
AU2003294100A8
AU2003294100A8 AU2003294100A AU2003294100A AU2003294100A8 AU 2003294100 A8 AU2003294100 A8 AU 2003294100A8 AU 2003294100 A AU2003294100 A AU 2003294100A AU 2003294100 A AU2003294100 A AU 2003294100A AU 2003294100 A8 AU2003294100 A8 AU 2003294100A8
Authority
AU
Australia
Prior art keywords
hyaluronic acid
respiratory disorders
upper airways
airways
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294100A
Other versions
AU2003294100A1 (en
Inventor
Edith Puchelle
Jean-Marie Zahm
Martine Briet
Beatrice Raby
Regis De Baynast
Franck Launay
Anthony Bresin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Agro Industrie Recherches et Developpements ARD filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2003294100A1 publication Critical patent/AU2003294100A1/en
Publication of AU2003294100A8 publication Critical patent/AU2003294100A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003294100A 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways Abandoned AU2003294100A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0214979A FR2847818B1 (en) 2002-11-28 2002-11-28 PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID
FR02/14979 2002-11-28
PCT/FR2003/003507 WO2004050187A1 (en) 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways

Publications (2)

Publication Number Publication Date
AU2003294100A1 AU2003294100A1 (en) 2004-06-23
AU2003294100A8 true AU2003294100A8 (en) 2004-06-23

Family

ID=32309802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294100A Abandoned AU2003294100A1 (en) 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways

Country Status (3)

Country Link
AU (1) AU2003294100A1 (en)
FR (1) FR2847818B1 (en)
WO (1) WO2004050187A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183709A1 (en) * 2005-02-15 2006-08-17 Ahmad Alkayali Preparation of low molecular weight hyaluronic acid as a food supplement
ITMI20060742A1 (en) 2006-04-13 2007-10-14 Patrizia Pattini ANTIBACTERIAL COMPOSITIONS FOR TREATMENT OF INFECTION OF HIGH AND LOW AIRCRAFT
FR2919185B1 (en) * 2007-07-23 2010-09-10 Ard Sa USE OF HYALURONIC ACID FOR THE PREPARATION OF COMPOSITIONS INTENDED TO IMPROVE THE CONDITION OF MUCOUS MEMBRANES
IT1396468B1 (en) * 2008-11-11 2012-12-14 Farma Derma Srl TOPIC USE OF HYALURONIC ACID FOR FILMOGEN ACTION IN PREPARATIONS FOR TREATMENT AND PROPHYLAXIS OF PATHOLOGIES OF THE RESPIRATORY PATHWAYS.
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
EP3415154A1 (en) 2017-06-16 2018-12-19 Sofibel S.A.S. Nasal composition
WO2023079072A1 (en) 2021-11-05 2023-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3310994B2 (en) * 1991-07-03 2002-08-05 電気化学工業株式会社 Allergy treatment
US5633003A (en) * 1994-03-31 1997-05-27 Cantor; Jerome O. Use of intratracheally administered hyaluronic acid to ameliorate emphysema
WO1999062546A1 (en) * 1998-06-01 1999-12-09 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
EP1292314A2 (en) * 2000-05-23 2003-03-19 The Trustees of Columbia University in the City of New York Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
AU2002315330A1 (en) * 2001-06-15 2003-01-02 Exhale Therapeutics, Inc. Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid

Also Published As

Publication number Publication date
WO2004050187A1 (en) 2004-06-17
AU2003294100A1 (en) 2004-06-23
FR2847818B1 (en) 2008-04-04
FR2847818A1 (en) 2004-06-04

Similar Documents

Publication Publication Date Title
HUS1400011I1 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
PL1656346T3 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
HK1102814A1 (en) Novel hydantoin derivatives for the treatment of obstructive airway diseases
AU2003233583A8 (en) Oral lactoferrin in the treatment of respiratory disorders
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
IL178815A0 (en) The treatment of respiratory disease
SI1530466T1 (en) Use of Nintedanib for the treatment of lung fibrosis
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
GB0410399D0 (en) The treatment of respiratory disease
AU2003294100A8 (en) Use of hyaluronic acid for respiratory disorders or the upper airways
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003273856A8 (en) Vr1 antagonists for the treatment of urological disorders
HRP20041159A2 (en) Combination for the treatment of airway disorders
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
PL370839A1 (en) Use of proton pump inhibitors for the treatment of airway disorders
GB0211414D0 (en) Treatment of respiratory disorders
GB0224330D0 (en) Treatment of respiratory disorders
GB0224328D0 (en) Combination therapy for respiratory disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 29, PAGE(S) 7783 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.), APPLICATION NO. 2003294100, UNDER INID (71) CORRECT THE NAME TO READ INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.)